| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,323 |
8,430 |
$784K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,524 |
5,712 |
$381K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,615 |
968 |
$98K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
782 |
98 |
$88K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,083 |
2,188 |
$83K |
| 99199 |
Unlisted special service, procedure or report |
20,467 |
17,991 |
$72K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
788 |
457 |
$69K |
| 99454 |
|
2,219 |
1,433 |
$66K |
| 99457 |
|
1,835 |
1,103 |
$43K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,493 |
915 |
$38K |
| 99458 |
|
1,530 |
844 |
$37K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
990 |
590 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
337 |
210 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,342 |
657 |
$12K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
78 |
52 |
$11K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
141 |
108 |
$11K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
98 |
83 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
891 |
604 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
599 |
341 |
$8K |
| 99443 |
|
153 |
91 |
$6K |
| 87428 |
|
147 |
85 |
$5K |
| 80306 |
|
279 |
211 |
$3K |
| 93923 |
|
24 |
16 |
$3K |
| 95924 |
|
24 |
16 |
$2K |
| 99406 |
|
252 |
147 |
$2K |
| 95923 |
|
24 |
16 |
$2K |
| 81002 |
|
939 |
585 |
$2K |
| 99215 |
Prolong outpt/office vis |
23 |
12 |
$1K |
| 99453 |
|
102 |
75 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
38 |
22 |
$1K |
| 93000 |
|
81 |
60 |
$877.04 |
| 99442 |
|
17 |
16 |
$823.04 |
| 95117 |
|
124 |
34 |
$820.57 |
| 86328 |
|
44 |
17 |
$768.91 |
| 87430 |
|
284 |
123 |
$757.52 |
| 99205 |
Prolong outpt/office vis |
20 |
15 |
$632.62 |
| 99407 |
|
30 |
25 |
$465.46 |
| 99441 |
|
15 |
12 |
$339.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
62 |
42 |
$321.99 |
| 90688 |
|
48 |
31 |
$211.91 |
| 81025 |
|
19 |
12 |
$101.40 |
| 96127 |
|
20 |
16 |
$66.90 |
| 98960 |
|
25 |
13 |
$56.56 |
| 99490 |
Ccm add 20min |
23 |
12 |
$54.04 |
| 99439 |
|
26 |
12 |
$46.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
111 |
39 |
$28.96 |
| 99173 |
|
112 |
49 |
$24.54 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
86 |
27 |
$5.44 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
36 |
26 |
$0.02 |
| 1036F |
|
23 |
15 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
20 |
12 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
22 |
13 |
$0.00 |
| 1111F |
|
17 |
12 |
$0.00 |
| 4004F |
|
23 |
12 |
$0.00 |